Advertisement
UK markets close in 7 hours 57 minutes
  • FTSE 100

    8,090.94
    +50.56 (+0.63%)
     
  • FTSE 250

    19,625.73
    -93.64 (-0.47%)
     
  • AIM

    754.15
    -0.54 (-0.07%)
     
  • GBP/EUR

    1.1657
    +0.0012 (+0.10%)
     
  • GBP/USD

    1.2498
    +0.0036 (+0.28%)
     
  • Bitcoin GBP

    51,414.43
    -2,058.67 (-3.85%)
     
  • CMC Crypto 200

    1,391.16
    +8.58 (+0.62%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    82.94
    +0.13 (+0.16%)
     
  • GOLD FUTURES

    2,334.50
    -3.90 (-0.17%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,298.51
    +97.24 (+0.57%)
     
  • DAX

    18,016.95
    -71.75 (-0.40%)
     
  • CAC 40

    8,079.68
    -12.18 (-0.15%)
     

BUZZ-Nanoco: cuts revenue forecast

** Nanoco biggest FTSE Small Cap loser after the nanotechnology co cuts revenue forecast due to lower royalty payments from Dow Chemical (Hanover: DCH1.HA - news)

** Co says an agreement allowing Dow to licence its cadmium-free quantum dot technology has been modified, resulting in lower royalty rates and no earn-out income for Nanoco

** Co partnered with Dow Chemical in 2014

** Prior to the announcement, analysts expected co's FY revenue at 4.99 mln stg vs 2.03 mln stg last yr

** Liberum analysts say change is expected to reduce Nanoco's FY16 sales levels below Liberum's 5 mln stg forecast and could also hurt their forecast for FY17

ADVERTISEMENT

** The analysts add Nanoco is potentially a more appealing M&A target than it was under an exclusive supply relationship with Dow

** Stock down 8.7 pct (RM (LSE: RM.L - news) : noor.hussain.thomsonreuters.com@reuters.net)